Related references
Note: Only part of the references are listed.Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
Yuhong Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
Svetlana Paskas et al.
INVESTIGATIONAL NEW DRUGS (2019)
Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says NO to antitumor immune response
Jon Penarando et al.
TRANSLATIONAL RESEARCH (2019)
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
Eric Fountain et al.
CANCERS (2019)
Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma
Nyasia M. Jones et al.
BMC CANCER (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma
Svetlana Paskas et al.
MOLECULAR CARCINOGENESIS (2019)
Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
Laura Soumoy et al.
CANCERS (2019)
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Ernesto Rossi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
Maria Cristina Petralia et al.
MOLECULES (2019)
Prognostic Value of Inducible Nitric Oxide Synthase (iNOS) in Human Cancer: A Systematic Review and Meta-Analysis
Wenbiao Liao et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
Jared M. Newton et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
Sven Gunther et al.
DRUG DISCOVERY TODAY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Differential modulation and prognostic values of immune-escape genes in uveal melanoma
Maria Sofia Basile et al.
PLOS ONE (2019)
Immune cells in the retina and choroid: Two different tissue environments that require different defenses and surveillance
Paul G. McMenamin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2019)
Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience
Vidhya Karivedu et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE (2019)
Prognostic value of DcR3 in solid tumors: A meta-analysis
Hua Ge et al.
CLINICA CHIMICA ACTA (2018)
Nitric oxide donors for prostate and bladder cancers: Current state and challenges
Amedea B. Seabra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets
Paolo Fagone et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
Joseph J. Sacco et al.
FUTURE ONCOLOGY (2018)
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
Paolo Fagone et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Alexander M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
Mario Presti et al.
ONCOLOGY LETTERS (2018)
Induction of anergic or regulatory tumor-specific CD4(+) T cells in the tumor-draining lymph node
Ruby Alonso et al.
NATURE COMMUNICATIONS (2018)
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
Katia Mangano et al.
Oncotarget (2018)
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
Xiaoxiang Zhou et al.
FRONTIERS IN PHYSIOLOGY (2018)
Immune Privilege and Eye-Derived T-Regulatory Cells
Hiroshi Keino et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
Hui-Jun Zhao et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
Muhammad Zubair Afzal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Expression of tryptophan-2, 3-dioxygense (TDO) in metastatic uveal melanoma
Mizue Terai et al.
CANCER RESEARCH (2018)
Targeting the IDO1 pathway in cancer: from bench to bedside
Ming Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series
Jiahe Zheng et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
Maria Sofia Basile et al.
MOLECULES (2018)
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Shelly Kalaora et al.
CANCER DISCOVERY (2018)
1127OA personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer
P A Ott et al.
ANNALS OF ONCOLOGY (2018)
1247PDPhase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)
J M Piulats Rodriguez et al.
ANNALS OF ONCOLOGY (2018)
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
Claire Mignard et al.
JOURNAL OF ONCOLOGY (2018)
Treatment of uveal melanoma: where are we now?
Jessica Yang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Focus on cutaneous and uveal melanoma specificities
Charlotte Pandiani et al.
GENES & DEVELOPMENT (2017)
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review
Jerome R. Lechien et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Inflammatory cell infiltrates in advanced metastatic uveal melanoma
Yamini Krishna et al.
HUMAN PATHOLOGY (2017)
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
Hanke L. Matlung et al.
IMMUNOLOGICAL REVIEWS (2017)
TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model
Saeed Daneshmandi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Melanoma subtypes demonstrate distinct PD-L1 expression profiles
Genevieve J. Kaunitz et al.
LABORATORY INVESTIGATION (2017)
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
Smita S. Chandran et al.
LANCET ONCOLOGY (2017)
Systematic genomic and translational efficiency studies of uveal melanoma
Chelsea Place Johnson et al.
PLOS ONE (2017)
Liver-Resident NK Cells: The Human Factor
Victoria Male
TRENDS IN IMMUNOLOGY (2017)
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
Paolo Fagone et al.
SCIENTIFIC REPORTS (2017)
Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review
Tomasz Berus et al.
ANTICANCER RESEARCH (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
Luke D. Rothermel et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Outcomes in Metastatic Uveal Melanoma Treated With PD-1 and PD-L1 Antibodies
Alain P. Algazi et al.
CANCER (2016)
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
A. M. M. Eggermont et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nitric oxide signaling in human ovarian cancer: A potential therapeutic target
Ahmed El-Sehemy et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2016)
In-depth proteomic profiling of the uveal melanoma secretome
Martina Angi et al.
ONCOTARGET (2016)
Uveal melanoma as a target for immune-therapy
Marc Oliva et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis
Yoshitaka Kimura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
Troels H. Borch et al.
DRUG DISCOVERY TODAY (2015)
NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases
Leila Sadegh et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
Danijela Maksimovic-Ivanic et al.
LEUKEMIA RESEARCH (2015)
A phase 2 study of tremelimumab in patients with advanced uveal melanoma
Anthony M. Joshua et al.
MELANOMA RESEARCH (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
Mark J. de Lange et al.
PLOS ONE (2015)
Immunogenicity of somatic mutations in human gastrointestinal cancers
Eric Tran et al.
SCIENCE (2015)
Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
Mieke Versluis et al.
PLOS ONE (2015)
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
Camila S. Oliveira et al.
BMC CANCER (2014)
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease
Susan Achberger et al.
MOLECULAR IMMUNOLOGY (2014)
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
M. Maio et al.
ANNALS OF ONCOLOGY (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice
Bastian Hoechst et al.
HEPATOLOGY (2012)
Influence of CD8+T regulatory cells on intraocular tumor development
Kyle C. McKenna et al.
FRONTIERS IN IMMUNOLOGY (2012)
Good news-bad news: the Yin and Yang of immune privilege in the eye
John V. Forrester et al.
FRONTIERS IN IMMUNOLOGY (2012)
Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?
Jerry Y. Niederkorn
FRONTIERS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Intratumoral Forkhead Box P3-Positive Regulatory T Cells Predict Poor Survival in Cyclooxygenase-2 Positive Uveal Melanoma
Dimitrios Mougiakakos et al.
CANCER (2010)
Expression and prognostic significance of iNOS in uveal melanoma
C. Christian Johansson et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Inflammatory Cytokines in Eyes with Uveal Melanoma and Relation with Macrophage Infiltration
Long V. Ly et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
Thomas van den Bosch et al.
DERMATOLOGY RESEARCH AND PRACTICE (2010)
CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation
S. K. Holfort et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Uveoscleral outflow - A review
Albert Alm et al.
EXPERIMENTAL EYE RESEARCH (2009)
Evidence for Natural Killer Cell-Mediated Protection from Metastasis Formation in Uveal Melanoma Patients
Willem Maat et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Molecular pathways mediating liver metastasis in patients with uveal melanoma
Silvin Bakalian et al.
CLINICAL CANCER RESEARCH (2008)
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma
Willem Maat et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Differential expression of chemokine receptors on uveal melanoma cells and their metastases
Haochuan Li et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro
Wanhua Yang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8(+) T cell tolerance
Linda Diehl et al.
HEPATOLOGY (2008)
Uveal melanoma expression of indoleamine 2,3-deoxygenase: Establishment of an immune privileged environment by tryptophan depletion
Peter W. Chen et al.
EXPERIMENTAL EYE RESEARCH (2007)
Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor
Yang-Hwan Ryu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients
Georg Weinlich et al.
DERMATOLOGY (2007)
Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer
K. Ino et al.
BRITISH JOURNAL OF CANCER (2006)
Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye
Kyle C. McKenna et al.
JOURNAL OF IMMUNOLOGY (2006)
Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression
SC Beutelspacher et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes
S Camelo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells
G Brandacher et al.
CLINICAL CANCER RESEARCH (2006)
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis
F Nicoletti et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma
T Ishio et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Nitric oxide, a mediator of inflammation, suppresses tumorigenesis
SP Hussain et al.
CANCER RESEARCH (2004)
Autocrine secretion of fas ligand shields tumor cells from fas-mediated killing by cytotoxic lymphocytes
K Hallermalm et al.
CANCER RESEARCH (2004)
Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells
YG He et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma
CS Vetter et al.
BRITISH JOURNAL OF CANCER (2004)
The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye
S Camelo et al.
JOURNAL OF IMMUNOLOGY (2004)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
C Uyttenhove et al.
NATURE MEDICINE (2003)
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes
C Pirker et al.
MELANOMA RESEARCH (2003)
CD200 and membrane protein E interactions in the control of myeloid cells
AN Barclay et al.
TRENDS IN IMMUNOLOGY (2002)
Interferon-γ reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells
IC Le Poole et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value
G Anastassiou et al.
JOURNAL OF PATHOLOGY (2001)
Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
RM Hoek et al.
SCIENCE (2000)
IFN-γ can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen
GL Beatty et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
